-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Therapeutic monoclonal antibodies (mAbs), such as anti-CD20 rituximab (RTX) for non-Hodgkin's lymphoma (NHL) and trastuzumab/herceptin for breast cancer (anti-Her2) change the tradition The way of cancer treatment has revolutionized cancer treatment.
Therapeutic monoclonal antibodies (mAbs), such as anti-CD20 rituximab (RTX) for non-Hodgkin's lymphoma (NHL) and trastuzumab/herceptin for breast cancer (anti-Her2) change the tradition The way of cancer treatment has revolutionized cancer treatment.
In order to create a favorable system successfully implanted human cells, the lack of a common cytokine receptor γ chain (IL- 2Rγ) advanced immunodeficiency NOD.
Lack of common cytokine receptor γ chain (IL- 2Rγ) advanced immunodeficiency NOD.
In this study, a new strain of NSG established a humanized mouse model, i.
-Hc1 Prkdc SCID -Hc1
The results of the study are as expected.
-Hc1 -Hc1
In summary, NSG- Hc1 mice can be used as a viable model, which can be used to study the use of cancer-targeted anti-tumor therapies, and to understand the induction mechanism of anti-tumor cell immune responses.
NSG- Hc1 mice can be used as a viable model, which can be used to study the use of cancer-targeted anti-tumor therapies, and to understand the induction mechanism of anti-tumor cell immune responses.
-Hc1 WenJ ,WangL ,RenJ WenJ Wen WangL Wang RenJ Ren , et al.
bmj.
com/content/9/2/e001524" target="_blank" rel="noopener">Nanoencapsulated rituximab mediates superior cellular immunity against metastatic B-cell lymphoma in a complement competent humanized mouse model.
Journal for ImmunoTherapy of Cancer 2021; 9: e001524.
doi: 10.
1136/jitc-2020-001524 doi: leave a message here